Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2000
11/15/2000EP1052287A2 Complex for transferring an anionic substance of interest into a cell
11/15/2000EP1052286A2 Growth hormone and growth hormone releasing hormone compositions
11/15/2000EP1052283A1 A method for the separation of rapeseed germ and rapeseed germ oil
11/15/2000EP1051625A1 Assessing risk for integrin antagonist/agonist mediated diseases
11/15/2000EP1051507A1 Antigen-specific cells, methods of generating these cells and uses thereof
11/15/2000EP1051503A1 METHOD FOR PRODUCING, BY PLANT CELLS, $g(a) 1?-ANTITRYPSIN AND ITS ALLELES, AND PRODUCTS CONTAINING THE RESULTING $g(a) 1?-ANTITRYPSIN
11/15/2000EP1051502A2 HIGHLY EFFICIENT CONTROLLED EXPRESSION OF EXOGENOUS GENES IN $i(E. COLI)
11/15/2000EP1051500A2 Diagnosis and treatment of aur1 and/or aur2 related disorders
11/15/2000EP1051499A2 Tyrosylprotein sulfotransferase polypeptides and polynucleotides
11/15/2000EP1051495A2 Recombinant mistletoe lectines
11/15/2000EP1051494A1 Methods and reagents for decreasing allergic reactions
11/15/2000EP1051492A1 Recombinant proteins from hgf and msp
11/15/2000EP1051491A1 EQUINE Fc EPSILON RECEPTOR ALPHA CHAIN NUCLEIC ACID MOLECULES, CORRESPONDING PROTEINS AND USES THEREOF
11/15/2000EP1051490A2 Modulation of cell proliferation, methods and reagents
11/15/2000EP1051489A2 Compounds for therapy and diagnosis of lung cancer and methods for their use
11/15/2000EP1051488A2 Human growth factor homologs
11/15/2000EP1051487A1 Placental protein 13
11/15/2000EP1051486A1 Gtpase derived from human lymph nodes that effects the morphology and cytoskeleton organization of endothelial cells
11/15/2000EP1051485A1 Trek-1 like two pore potassium channel
11/15/2000EP1051482A1 Cytotoxic heteromeric protein combinatorial libraries
11/15/2000EP1051481A1 Secreted proteins and polynucleotides encoding them
11/15/2000EP1051479A1 Novel steroid-activated nuclear receptors and uses therefor
11/15/2000EP1051434A1 G protein-coupled receptor
11/15/2000EP1051433A2 Antimicrobial peptides
11/15/2000EP1051432A2 Method for reducing immunogenicity of proteins
11/15/2000EP1051429A1 Ldl related protein and uses thereof
11/15/2000EP1051428A1 Human cystatin f
11/15/2000EP1051427A1 Spoil protein and nucleic acid molecules and uses therefor
11/15/2000EP1051426A1 67 human secreted proteins
11/15/2000EP1051187A1 Treatment of follicular lymphomas using inhibitors of the lymphotoxin (lt) pathway
11/15/2000EP0832191A4 Recombinant viral nucleic acids
11/15/2000EP0828826A4 Plant promoter activated by fungal infection
11/15/2000EP0808374A4 Method for modulating processes mediated by farnesoid activated receptors
11/15/2000EP0771359A4 Construction of nucleoprotein based assemblies comprising addressable components for nanoscale assembly and nanoprocessors
11/15/2000EP0765343B1 MONOCLONAL ANTIBODY ACTIVE AGAINST CD44v6
11/15/2000EP0717635B1 Methods for regulating gastrointestinal motility
11/15/2000EP0716710B1 Methods of suppressing immune response by gene therapy
11/15/2000EP0658168B1 Antibodies specific for a haemostatic protein, their use for isolating intact protein, haemostatic compositions devoid of proteolytic cleavage products of the protein
11/15/2000EP0650371B1 Covalent polar lipid-peptide conjugates for biological targeting
11/15/2000EP0601129B1 Morphogenic protein screening method
11/15/2000EP0592423B1 Methods for the identification of cytokine convertase inhibitors
11/15/2000CN1273606A The use of mixed duplex oligonucleotides to effect localized genetic changes in plants
11/15/2000CN1273605A Mass production method of antimicrobial peptide and DNA construct and expression system thereof
11/15/2000CN1273604A Antifreeze proteins, DNA and expression system
11/15/2000CN1273603A Attenuated respiratory syncytial viruses
11/15/2000CN1273588A Amino acid sequences for therapeutical and prophylacticapplications to disedses due to i (clostridium difficile) toxinc
11/15/2000CN1273533A I (Robinia Pseudoacacia) lectin and its uses
11/15/2000CN1273248A Efficient gene engineering process for preparing polypeptide medicines
11/15/2000CN1058524C Heat tolerant phytases
11/15/2000CN1058500C Thymosin alpha-1 derivatives
11/14/2000US6147282 Method of controlling the fertility of a plant
11/14/2000US6147281 Antipathogenic peptides and compositions containing same
11/14/2000US6147275 Corticotropin releasing factor receptor 1-deficient mice
11/14/2000US6147255 Topical and systemic treatment of dermatological complaints associated with keratinization disorder which has effect on differentiation and on proliferation
11/14/2000US6147204 Complex for targeting therapeutic or diagnostic agents to preferential biological target
11/14/2000US6147203 Recombinant disulfide-stabilized polypeptide fragments having binding specificity
11/14/2000US6147202 Nucleotide sequences coding erythrocyte proteins; for utilization in blood transfusions
11/14/2000US6147201 Nucleotide sequences coding acarnia protein; for the diagnosis and treatment of sensitivity to acarnia allergy proteins
11/14/2000US6147192 Proteins associated with weight control; for the treatmen of eating disorders
11/14/2000US6147191 Protein associated with mylein and the central nervous system; for the diagnosis and treatment of multiple sclerosis and autoimmune diseases
11/14/2000US6147190 Protein associated with activating cell propagation; for the treatment of a nervous system disorders; for diagnosis and treatment of tumors; antitumor agents
11/14/2000US6147189 Biosynthesis of structurally confined protein; synthesize a protein with a tripeptide active position composed of arginine, glycine, asparagine and proline residues at terminals .
11/14/2000US6147188 Irreversible cathepsin or calpain inhibitors
11/14/2000US6147187 Major histocompatibility complex proteins; for diagnosis and treatment of tumors; antitumor agents
11/14/2000US6147186 Receptor agonist for treating osteoporosis
11/14/2000US6147057 Immunogenic composition
11/14/2000US6147055 Cancer treatment method utilizing plasmids suitable for IL-2 expression
11/14/2000US6147052 Method of differentiating erythrocyte progenitor cells
11/14/2000US6147050 5-lipoxygenase-activating protein II
11/14/2000US6146894 Method for generating hypermutable organisms
11/14/2000US6146888 Amplification of preferential cell population; mixing cells in which the genome codes an antibiotic resistance gene, recovering cells that propagate in the presence of antibiotic
11/14/2000US6146885 Plasmid for transfer of genes into vertebrate cells
11/14/2000US6146878 Tyrosine repressor gene of a bacterium belonging to the genus Erwinia
11/14/2000US6146877 Identification of the progression elevated gene-3 and uses thereof
11/14/2000US6146870 Flea protease proteins
11/14/2000US6146863 Staphylococcus aureus 3-hydroxyacyl-CoA dehydrogenase
11/14/2000US6146852 Production of human parathyroid hormone from microorganisms
11/14/2000US6146851 DNA encoding NV2 (long form) and carboxy truncated fragments thereof
11/14/2000US6146850 Proteins encoding gelonin sequences
11/14/2000US6146849 Recombinant dna which codes for a mature calcium-dependent lectin having a defined amino acid sequence; for recombinant production
11/14/2000US6146848 Bacterial expression system
11/14/2000US6146846 Primosome protein a of streptococcus pneumoniae
11/14/2000US6146845 Polynucleotides encoding a sialoadhesin family member-2 (SAF-2)
11/14/2000US6146837 Detecting fc gamma receptor (cd64) in a biological sample by conacting sample with cyanin compound, cy5; illuminating the sample with light of an appropriate excitation wavelength; and detecting fluorescence
11/14/2000US6146835 Nucleotide sequence; for drug screening of novel analgesics; for recombinant production of receptor
11/14/2000US6146831 Cellular models for diabetes and other diseases associated with mitochondrial defects
11/14/2000US6146829 Gapped 2' modified oligonucleotides
11/14/2000US6146827 Detecting nucleic acid involved in g protein mediated signal transduction in a t helper cell sample
11/14/2000US6146826 Green fluorescent protein
11/14/2000US6146643 A hepatitis a virus having a genome consisting of a human attenuated hepatitis a virus sequence wherein the 5' noncoding region has been replaced by the 5' noncoding region of simian hepatitis a virus agm-27
11/14/2000US6146642 Recombinant new castle disease virus RNA expression systems and vaccines
11/14/2000US6146641 Avian leukosis virus subgroup J envelope gene product for diagnosis and immunogenic composition
11/14/2000US6146635 System for the expression of heterologous antigens as fusion proteins
11/14/2000US6146634 Proteins with urease activity
11/14/2000US6146633 Endogenous and exogenous proteins, and fragments are chemically modified outside the body of an animal so that when injected into the animal, they produce more antibodies against the unmodified protein unmodified protein alone
11/14/2000US6146631 Administering a fusion protein comprising a gelonin prefered amino acid sequeance, a targeting sequence that allows internalization of fusion protein in the cell, internizing the fusion protein in the cell, eliminating the cell
11/14/2000US6146628 Biotherapeutic agents comprising recombinant PAP and PAP mutants
11/14/2000US6146624 Human ubiquitin-conjugating enzymes
11/14/2000CA2074839C Modified factor vii anticoagulant proteins
11/14/2000CA1341140C Structural phosphoprotein (pp28) of human cytomegalovirus (hcmv), the preparation and use thereof
1 ... 2094 2095 2096 2097 2098 2099 2100 2101 2102 2103 2104 2105 2106 2107 2108 2109 2110 2111 2112 2113 2114 ... 2916